Ken Griffin Enovis Corp Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$44.56 - $62.43 $748,608 - $1.05 Million	-16,800 Reduced 77.06%	5,000 $226,000
Q1 2024 May 15, 2024	BUY	$55.44 - $63.8 $774,940 - $891,796	13,978 Added 178.7%	21,800 $1.36 Million
Q4 2023 Feb 14, 2024	SELL	$43.67 - $57.07 $34,936 - $45,656	-800 Reduced 9.28%	7,822 $438,000
Q3 2023 Nov 14, 2023	BUY	$51.65 - $65.54 $98,135 - $124,526	1,900 Added 28.27%	8,622 $454,000
Q2 2023 Aug 14, 2023	SELL	$52.7 - $64.12 $63,240 - $76,944	-1,200 Reduced 15.15%	6,722 $431,000
Q1 2023 May 15, 2023	SELL	$49.5 - $65.92 $242,203 - $322,546	-4,893 Reduced 38.18%	7,922 $423,000
Q4 2022 Feb 14, 2023	BUY	$44.83 - $57.43 $242,082 - $310,122	5,400 Added 72.83%	12,815 $685,000
Q3 2022 Nov 14, 2022	BUY	$46.07 - $60.1 $341,609 - $445,641	7,415 New	7,415 $342,000

301

59.9M

1.63M

576K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.6B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.